Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C77H96ClF3N10O10S4 |
| Molecular Weight | 1542.355 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CCCCCC(=O)N2CCN(CC[C@H](CSC3=CC=CC=C3)NC4=C(C=C(C=C4)S(=O)(=O)NC(=O)C5=CC=C(C=C5)N6CCN(CC7=C(CCC(C)(C)C7)C8=CC=C(Cl)C=C8)CC6)S(=O)(=O)C(F)(F)F)CC2)C(C)(C)C)C9=CC=C(C=C9)C%10=C(C)N=CS%10
InChI
InChIKey=PXVFFBGSTYQHRO-REQIQPEASA-N
InChI=1S/C77H96ClF3N10O10S4/c1-51(53-18-20-55(21-19-53)70-52(2)82-50-103-70)83-73(96)66-44-61(92)48-91(66)74(97)71(75(3,4)5)85-68(93)16-12-9-13-17-69(94)90-42-36-87(37-43-90)35-33-59(49-102-62-14-10-8-11-15-62)84-65-31-30-63(45-67(65)104(98,99)77(79,80)81)105(100,101)86-72(95)56-24-28-60(29-25-56)89-40-38-88(39-41-89)47-57-46-76(6,7)34-32-64(57)54-22-26-58(78)27-23-54/h8,10-11,14-15,18-31,45,50-51,59,61,66,71,84,92H,9,12-13,16-17,32-44,46-49H2,1-7H3,(H,83,96)(H,85,93)(H,86,95)/t51-,59+,61+,66-,71+/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
865621
Created by
admin on Sat Dec 16 10:16:19 GMT 2023 , Edited by admin on Sat Dec 16 10:16:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
139331475
Created by
admin on Sat Dec 16 10:16:19 GMT 2023 , Edited by admin on Sat Dec 16 10:16:19 GMT 2023
|
PRIMARY | |||
|
2365172-42-3
Created by
admin on Sat Dec 16 10:16:19 GMT 2023 , Edited by admin on Sat Dec 16 10:16:19 GMT 2023
|
PRIMARY | |||
|
Y8JQ9V7JAJ
Created by
admin on Sat Dec 16 10:16:19 GMT 2023 , Edited by admin on Sat Dec 16 10:16:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
